About Ironshore Pharmaceuticals
Ironshore Pharmaceuticals is a company based in George Town (Cayman Islands) founded in 2008 was acquired by Collegium Pharma in July 2024.. Ironshore Pharmaceuticals offers products and services including Medications Portfolio. Ironshore Pharmaceuticals operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter George Town, Cayman Islands
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ironshore Pharmaceuticals Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$143 M (USD), Debt – Conventional
Aug 14, 2018
-
Investors
Morgan Stanley
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Collegium Pharma
(Jul 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ironshore Pharmaceuticals
Ironshore Pharmaceuticals offers a comprehensive portfolio of products and services, including Medications Portfolio. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for serious medical conditions through scientific development
Unlock access to complete
Unlock access to complete
Funding Insights of Ironshore Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $143.0M
-
First Round
First Round
(24 Jan 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Debt – Conventional - Ironshore Pharmaceuticals | Valuation |
investors |
|
| Jan, 2017 | Amount | Debt – Conventional - Ironshore Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ironshore Pharmaceuticals
Ironshore Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Morgan Stanley and Collegium Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wealth management, investment advisory, and financial services are provided.
|
Founded Year | Domain | Location | |
|
Abuse-deterrent extended-release therapeutics for chronic pain are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ironshore Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ironshore Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ironshore Pharmaceuticals Comparisons
Competitors of Ironshore Pharmaceuticals
Ironshore Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ironshore Pharmaceuticals
Frequently Asked Questions about Ironshore Pharmaceuticals
When was Ironshore Pharmaceuticals founded?
Ironshore Pharmaceuticals was founded in 2008 and raised its 1st funding round 9 years after it was founded.
Where is Ironshore Pharmaceuticals located?
Ironshore Pharmaceuticals is headquartered in George Town, Cayman Islands.
What does Ironshore Pharmaceuticals do?
Ironshore Pharmaceuticals was founded in 2008 in George Town, Cayman Islands, within the pharmaceuticals sector. Drug delivery technology and treatments for attention deficit hyperactivity disorder are developed, with proprietary Delexis utilized for controlled drug release during ingestion and absorption. Operations focus on central nervous system stimulants, including the flagship prescription medicine JORNAY PM for ADHD management. Activities center on therapeutic innovation in this niche area.
Who are the top competitors of Ironshore Pharmaceuticals?
Ironshore Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Ironshore Pharmaceuticals offer?
Ironshore Pharmaceuticals offers Medications Portfolio.
Who are Ironshore Pharmaceuticals's investors?
Ironshore Pharmaceuticals has 2 investors. Key investors include Morgan Stanley, and Collegium Pharma.